Others

Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on February 20, 2019 Published on February 20, 2019

Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris™, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual MeetingGlenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris™, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting

Pdf Link: Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on February 20, 2019
This article is closed for comments.
Please Email the Editor